Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Finland
  4. Nasdaq Helsinki
  5. Nanoform Finland Oyj
  6. Summary
    NANOFH   FI4000330972

NANOFORM FINLAND OYJ

(NANOFH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Helsinki
07/26/2021 07/27/2021 07/28/2021 07/29/2021 07/30/2021 Date
6.93(c) 7.09(c) 7.13(c) 7.14(c) 7.1(c) Last
56 814 48 368 8 448 8 254 12 721 Volume
-2.39% +2.31% +0.56% +0.14% -0.56% Change
More quotes
Estimated financial data (e)
Sales 2021 2,85 M 3,38 M 3,38 M
Net income 2021 - - -
Net cash position 2021 74,9 M 88,9 M 88,9 M
P/E ratio 2021 -26,3x
Yield 2021 -
Sales 2022 9,35 M 11,1 M 11,1 M
Net income 2022 - - -
Net cash position 2022 55,4 M 65,7 M 65,7 M
P/E ratio 2022 -27,3x
Yield 2022 -
Capitalization 515 M 611 M 611 M
EV / Sales 2021 154x
EV / Sales 2022 49,2x
Nbr of Employees 87
Free-Float 68,0%
More Financials
Company
Nanoform Finland Oyj is a Finland-based limited liability Company offering services in nanotechnology and drug particle engineering for the international pharma industry. The Company’s affairs consist of both internal research and development activities and proof of concept type of research and development services provided to customers. 
Sector
Pharmaceuticals
Calendar
-
More about the company
Ratings of Nanoform Finland Oyj
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about NANOFORM FINLAND OYJ
06/14NANOFORM FINLAND OYJ : Plc – Manager's transactions – Gonçalo Andrad..
PU
06/14NANOFORM FINLAND PLC : - Manager's transactions - Gonçalo Andrade
AQ
06/11NANOFORM FINLAND OYJ : Share subscriptions based on Nanoform Finland Plc's multi..
PU
06/11NANOFORM FINLAND OYJ : The Board of Directors of Nanoform Finland Plc decided on..
AQ
06/11NANOFORM FINLAND OYJ : Share subscriptions based on Nanoform Finland Plc's multi..
AQ
06/02NANOFORM FINLAND OYJ : Upgrades Business Targets For 2025; Shares Up 8%
MT
06/02NANOFORM FINLAND OYJ : raises its mid-term business targets for 2025
AQ
05/29Certain Shares of Nanoform Finland Oyj are subject to a Lock-Up Agreement End..
CI
05/27NANOFORM FINLAND OYJ : Interim Report January – March (Q1) 2021
PU
05/27NANOFORM FINLAND OYJ : Interim Report January - March (Q1) 2021
AQ
05/27Nanoform Finland Oyj Reports Earnings Results for the First Quarter Ended Mar..
CI
05/25NANOFORM FINLAND OYJ : and Celanese Explore Ways to Enhance Drug Delivery
AQ
05/20NANOFORM FINLAND OYJ : Cynthia Schwalm transitions to Senior Advisor Business De..
AQ
05/20Cynthia Schwalm Resigns from Nanoform's Board of Directors
CI
05/18NANOFORM FINLAND OYJ : final clinical results confirm value proposition to the p..
PU
More news
News in other languages on NANOFORM FINLAND OYJ

- No features available -

More news
Chart NANOFORM FINLAND OYJ
Duration : Period :
Nanoform Finland Oyj Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NANOFORM FINLAND OYJ
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 7,10 €
Average target price 9,15 €
Spread / Average Target 28,9%
EPS Revisions
Managers and Directors
Edward Hæggström Chief Executive Officer
Albert Alexander Hæggström Chief Financial Officer & Director
Miguel Maria de Oliveira Barreiros Calado Chairman
Niklas Sandler Chief Technology Officer
Gonçalo Nuno N. da Silva Rebelo de Andrade Chief Business Operations
Sector and Competitors
1st jan.Capi. (M$)
NANOFORM FINLAND OYJ0.28%611
JOHNSON & JOHNSON9.42%453 313
ROCHE HOLDING AG13.38%337 105
PFIZER, INC.16.30%239 637
NOVARTIS AG0.28%225 343
ELI LILLY AND COMPANY44.22%221 348